Bayer appoints new Head of Human Resources in Australia & New Zealand

Karina Raeburn, new Head of Human Resources for the Bayer Group, Australia and New Zealand, succeeds Isadore Payne who will retire from his role after 10 years with the company. 

Sydney, 15 July 2021 – Bayer is pleased to announce Karina Raeburn as the new Head of Human Resources for the Bayer Group, Australia and New Zealand. Ms. Raeburn, currently HR Business Partner Pharmaceuticals division of Bayer in ANZ, succeeds Isadore Payne who will retire from his role after 10 years with the company. 

 

Ms. Raeburn will assume responsibility for Bayer’s local Human Resources organisation on 1 August, reporting to Joerg Ellmanns, Chairman and Managing Director Bayer Group (ANZ).  The role has responsibility for leading Bayer’s people and culture agenda across the three Bayer divisions – Pharmaceuticals, Consumer Health and Crop Science, as well as the corporate functions.  

 

“The team at Bayer thanks Isadore for his valuable, long-standing contributions and dedication during his tenure at Bayer ANZ and we wish him all the very best with this well-deserved phase in his life,” said Mr. Ellmanns. “We’re pleased to confirm Karina as Isadore’s successor, as she brings extensive experience in leading talent management strategies that build high performance cultures of innovation and inclusion.” 

 

“It’s an exciting time to be working at Bayer, a purpose-driven global company which is tackling some of the world’s toughest challenges to promote health for all and hunger for none,” Ms. Raeburn commented. “I am very much looking forward to further advancing our people and culture agenda to lead the business through an exciting period of transformation and change.” 

 

During his time with the company as Head of Human Resources for Bayer, Mr. Payne has led numerous  local efforts to create Bayer ANZ as an inclusive and people-focused workplace where everyone contributes to the company’s purpose and have the opportunity to develop to their full potential. “It has been a joy and an honour to work with so many great colleagues and partners over the last 30 years of my career and to have had the opportunity to help transform organisations and cultures,” Mr. Payne said. “It has been a great opportunity to promote internal talent and I wish Karina every success in her new role,” he added.

 

Ms. Raeburn has spent three years with Bayer and has played an integral part in developing our inclusion and diversity strategy, supporting cultural transformation, and introducing flexible working strategies and initiatives across ANZ. She has worked with numerous executive teams and held HR leadership positions gained at Baker & McKenzie and KPMG. 


About Bayer
Bayer is a global enterprise with core competencies in the life science fields of health care, nutrition and agriculture. Its products and services are designed to help people and planet thrive by supporting efforts to master the major challenges presented by a growing and aging global population. Bayer is committed to drive sustainable development and generate a positive impact with its businesses. The company has operated in Australia since 1925 and has a long-term commitment to the health and nutrition of all Australians. Locally, Bayer currently employs almost 900 people across the country and is dedicated to servicing the needs of rural and remote communities. Bayer embraces and encourages its employees’ unique identities and advances a culture of inclusion and diversity across gender, LGBTQI+, generations, disability and race. For more information, go to www.bayer.com.au. 

 

Contact:
Fleur Wilkins, phone +61 427 065 697
Email: fleur.wilkins@bayer.com

 

Forward-Looking Statements 
This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer’s public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.